Kim Steegen

11PUBLICATIONS
49CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Immunogenetics (incl. genetic immunology)Causes and prevention of crimeGene and molecular therapyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 26, 2026
Optimizing HIV-1 Genotypic Resistance Testing for Low- and Middle-Income Countries: High-Impact HIV-1 Mutations Across WHO-Defined Scenarios.

|Jan 08, 2025
Thymidine Analogue Mutations with M184V Significantly Decrease Phenotypic Susceptibility of HIV-1 Subtype C Reverse Transcriptase to Islatravir.

Hyeonah Byun, Maria Antonia Papathanasopoulos, Kim Steegen

|Sep 28, 2024
K103N, V106M and Y188L Significantly Reduce HIV-1 Subtype C Phenotypic Susceptibility to Doravirine.

Nikita Reddy, Maria Papathanasopoulos, Kim Steegen

|Jan 23, 2024
Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi's National HIV Treatment Program.

Hope Kanise, Joep J van Oosterhout, Pachawo Bisani

|Sep 22, 2023
Recommendations on data sharing in HIV drug resistance research.

Seth C Inzaule, Mark J Siedner, Susan J Little

|Jul 14, 2023
Advancing HIV Drug Resistance Technologies and Strategies: Insights from South Africa's Experience and Future Directions for Resource-Limited Settings.

Kim Steegen, Gert U van Zyl, Mathilda Claassen

Pageof 2

Frequent Collaborators

2 joint publications

Adriaan Erasmus Basson

2 joint publications

Lucia Hans

2 joint publications

Robert W Shafer

2 joint publications

Rami Kantor